Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

被引:66
作者
Sinn, Hans-Peter [1 ]
Schneeweiss, Andreas [2 ]
Keller, Marius [1 ]
Schlombs, Kornelia [6 ]
Laible, Mark [6 ]
Seitz, Julia [2 ]
Lakis, Sotirios [4 ]
Veltrup, Elke [4 ]
Altevogt, Peter [3 ]
Eidt, Sebastian [5 ]
Wirtz, Ralph M. [4 ,5 ]
Marme, Frederik [2 ]
机构
[1] Heidelberg Univ, Inst Pathol, Neuenheimer Feld 220-221, D-69120 Heidelberg, Germany
[2] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Neuenheimer Feld 460, D-69120 Heidelberg, Germany
[3] German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[4] STRATIFYER Mol Pathol GmbH, Werthmannstr 1c, D-50935 Cologne, Germany
[5] St Elizabeth Hosp, Dept Pathol, Werthmannstr 1c, D-50935 Cologne, Germany
[6] BioNTech Diagnost GmbH, D-55131 Mainz, Germany
来源
BMC CANCER | 2017年 / 17卷
关键词
Image analysis; Breast cancer; Ki67; mRNA; RT-qPCR; Prediction; Pathologic complete response; neoadjuvant; Immunohistochemistry (IHC); MammaTyper (R); INTERNATIONAL EXPERT CONSENSUS; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; AUTOMATED ASSESSMENT; MOLECULAR SUBTYPES; PROGNOSTIC VALUE; CORE BIOPSIES; KI67; NEOADJUVANT; EXPRESSION;
D O I
10.1186/s12885-017-3111-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Proliferation may predict response to neoadjuvant therapy of breast cancer and is commonly assessed by manual scoring of slides stained by immunohistochemistry (IHC) for Ki-67 similar to ER and PgR. This method carries significant intra- and inter-observer variability. Automatic scoring of Ki-67 with digital image analysis (qIHC) or assessment of MKI67 gene expression with RT-qPCR may improve diagnostic accuracy. Methods: Ki-67 IHC visual assessment was compared to the IHC nuclear tool (AperioTM) on core biopsies from a randomized neoadjuvant clinical trial. Expression of ESR1, PGR and MKI67 by RT-qPCR was performed on RNA extracted from the same formalin-fixed paraffin-embedded tissue. Concordance between the three methods (vIHC, qIHC and RT-qPCR) was assessed for all 3 markers. The potential of Ki-67 IHC and RT-qPCR to predict pathological complete response (pCR) was evaluated using ROC analysis and non-parametric Mann-Whitney Test. Results: Correlation between methods (qIHC versus RT-qPCR) was high for ER and PgR (spearman's r = 0.82, p < 0.0001 and r = 0.86, p < 0.0001, respectively) resulting in high levels of concordance using predefined cut-offs. When comparing qIHC of ER and PgR with RT-qPCR of ESR1 and PGR the overall agreement was 96.6 and 91.4%, respectively, while overall agreement of visual IHC with RT-qPCR was slightly lower for ER/ESR1 and PR/PGR (91.2 and 92.9%, respectively). In contrast, only a moderate correlation was observed between qIHC and RT-qPCR continuous data for Ki-67/MKI67 (Spearman's r = 0.50, p = 0.0001). Up to now no predictive cut-off for Ki-67 assessment by IHC has been established to predict response to neoadjuvant chemotherapy. Setting the desired sensitivity at 100%, specificity for the prediction of pCR (ypT0ypN0) was significantly higher for mRNA than for protein (68.9% vs. 22.2%). Moreover, the proliferation levels in patients achieving a pCR versus not differed significantly using MKI67 RNA expression (Mann-Whitney p = 0.002), but not with qIHC of Ki-67 (Mann-Whitney p = 0.097) or vIHC of Ki-67 (p = 0.131). Conclusion: Digital image analysis can successfully be implemented for assessing ER, PR and Ki-67. IHC for ER and PR reveals high concordance with RT-qPCR. However, RT- qPCR displays a broader dynamic range and higher sensitivity than IHC. Moreover, correlation between Ki-67 qIHC and RT-qPCR is only moderate and RT-qPCR with MammaTyper (R) outperforms qIHC in predicting pCR. Both methods yield improvements to error-prone manual scoring of Ki-67. However, RT-qPCR was significantly more specific.
引用
收藏
页数:10
相关论文
共 43 条
  • [11] Pragmatic issues in biomarker evaluation for targeted therapies in cancer
    de Gramont, Armand
    Watson, Sarah
    Ellis, Lee M.
    Rodon, Jordi
    Tabernero, Josep
    de Gramont, Aimery
    Hamilton, Stanley R.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (04) : 197 - 212
  • [12] Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial†
    Denkert, C.
    Loibl, S.
    Mueller, B. M.
    Eidtmann, H.
    Schmitt, W. D.
    Eiermann, W.
    Gerber, B.
    Tesch, H.
    Hilfrich, J.
    Huober, J.
    Fehm, T.
    Barinoff, J.
    Jackisch, C.
    Prinzler, J.
    Ruediger, T.
    Erbstoesser, E.
    Blohmer, J. U.
    Budczies, J.
    Mehta, K. M.
    von Minckwitz, G.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (11) : 2786 - 2793
  • [13] Computer-aided techniques for chromogenic immunohistochemistry: Status and directions
    Di Cataldo, Santa
    Ficarra, Elisa
    Macii, Enrico
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2012, 42 (10) : 1012 - 1025
  • [14] Biological subtypes of triple-negative breast cancer are associated with distinct morphological changes and clinical behaviour
    Elsawaf, Zeinab
    Sinn, Hans-Peter
    Rom, Joachim
    Bermejo, Justo Lorenzo
    Schneeweiss, Andreas
    Aulmann, Sebastian
    [J]. BREAST, 2013, 22 (05) : 986 - 992
  • [15] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Fasching, Peter A.
    Heusinger, Katharina
    Haeberle, Lothar
    Niklos, Melitta
    Hein, Alexander
    Bayer, Christian M.
    Rauh, Claudia
    Schulz-Wendtland, Ruediger
    Bani, Mayada R.
    Schrauder, Michael
    Kahmann, Laura
    Lux, Michael P.
    Strehl, Johanna D.
    Hartmann, Arndt
    Dimmler, Arno
    Beckmann, Matthias W.
    Wachter, David L.
    [J]. BMC CANCER, 2011, 11
  • [16] GERDES J, 1984, J IMMUNOL, V133, P1710
  • [17] Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
    Gianni, L
    Zambetti, M
    Clark, K
    Baker, J
    Cronin, M
    Wu, J
    Mariani, G
    Rodriguez, J
    Carcangiu, M
    Watson, D
    Valagussa, P
    Rouzier, R
    Symmans, WF
    Ross, JS
    Hortobagyi, GN
    Pusztai, L
    Shak, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (29) : 7265 - 7277
  • [18] Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
    Guarneri, V
    Broglio, K
    Kau, SW
    Cristofanilli, M
    Buzdar, AU
    Valero, V
    Buchholz, T
    Meric, F
    Middleton, L
    Hortobagyi, GN
    Gonzalez-Angulo, AM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1037 - 1044
  • [19] Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1200/JCO.2009.25.6529, 10.1200/JOP.777003, 10.5858/134.6.907]
  • [20] Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
    Harvey, JM
    Clark, GM
    Osborne, CK
    Allred, DC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1474 - 1481